Viewing SEC Facts Units
Company Name:
Amylyx Pharmaceuticals, Inc.
CIK:
1658551
Start Filing Date:
2022-04-01
End Filing Date:
2022-06-30
ACCN:
0000950170-22-016883
Value:
$ 58,275,903
Value Error:
$ None
Created By:
Date Filed:
2022-08-11
FY:
2022
Fiscal Period:
Q2
Frame:
CY2021Q2
Type:
us-gaap
Form:
10-Q
Units:
shares